26 August 2020 – MPA Webinar Series

Event #1 – Wed 26th August from 7pm to 830pm Topics: Dermatology and Melanoma Surgery Please register via the Eventbrite link: https://www.eventbrite.com.au/e/dermatology-and-melanoma-surgery-a-discussion-with-our-specialists-registration-116189932215?aff=ebdssbeac >> DOWNLOAD PDF for full details

Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website http://australasianmelanoma.org/

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Cancer in the News

Feature Articles

Hunt for Reliable Biomarkers for Immunotherapy Continues in Melanoma

Although immune checkpoint inhibitors have revolutionized the treatment of patients with melanoma, identifying reliable biomarkers of response to this approach has proven to be exceedingly challenging, according to Douglas B. Johnson, MD, MSCI.


Posted in Melanoma News, Health Professionals, Of Interest

Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

Since patients with stage I/IIA cutaneous melanoma (CM) are currently not eligible for adjuvant therapies despite relapse risk uncertainty, researchers examined the ability of a recently developed model that combines clinicopathologic and gene expression variables (CP-GEP) to identify patients with stage I/IIA melanoma who have a high risk for disease relapse.


Posted in Melanoma News, Health Professionals, Of Interest

Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests

Medicare Administrative Contractor CGS Administrators has aligned its coverage for melanoma risk stratification tests in patients with cutaneous melanoma, including Castle Biosciences’ DecisionDx-Melanoma test.


Posted in Melanoma News, Patients, Latest News

26th November 2020 – MRV Scientific Exchange, Public Forum

6:00 – 8:30pm 26th November 2020 MRV  Scientific Exchange, Public Forum Register via link: https://unimelb.zoom.us/webinar/register/WN_ZtbIh9u1QhyOqlOGDNq1WQ    


Posted in MRV Events, Events